-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AE46OcTVsjUFEzScXBFYYnfavV6KE+qI7o3Jg/VsfYF/nD2df2gTp465FGyUZnPu e+FT52mAY/IlEByzRYzHtg== 0000936392-99-000127.txt : 19990210 0000936392-99-000127.hdr.sgml : 19990210 ACCESSION NUMBER: 0000936392-99-000127 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990209 GROUP MEMBERS: ALLERGAN HOLDINGS, INC. GROUP MEMBERS: ALLERGAN INC GROUP MEMBERS: ALLERGAN PHARMACEUTICALS (IRELAND) LTD., INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-43329 FILM NUMBER: 99525648 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 6195353900 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 SC 13G/A 1 AMENDMENT #4 TO SCHEDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-11(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 4)* LIGAND PHARMACEUTICALS INCORPORATED - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 53220K 10 8 - -------------------------------------------------------------------------------- (CUSIP Number) 12/31/98 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - ----------------- 1. The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 pages 2 - --------------------------- 13G CUSIP NO. 53220K 10 8 - --------------------------- - --------- ---------------------------------------------------------------------- 1 Name of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Persons ALLERGAN, INC. - --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) |X| - --------- ---------------------------------------------------------------------- 3 SEC Use Only - --------- ---------------------------------------------------------------------- 4 Citizenship or Place of Organization DELAWARE - --------- ---------------------------------------------------------------------- 5 Sole Voting Power Number of 2,245,944 ------ ----------------------------------------------- Shares 6 Shared Voting Power Beneficially Owned by Each Reporting Person 0 with ------ ----------------------------------------------- 7 Sole Dispositive Power 2,245,944 ------ ----------------------------------------------- 8 Shared Dispositive Power 0 - --------- ---------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by each Reporting Person 2,245,944 - --------- ---------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) excludes certain shares* - --------- ---------------------------------------------------------------------- 11 Percent of Class represented by amount in Row 9 5.3% - --------- ---------------------------------------------------------------------- 12 Type of Reporting Person* CO - --------- ---------------------------------------------------------------------- Page 2 of 7 pages 3 - --------------------------- 13G CUSIP NO. 53220K 10 8 - --------------------------- - --------- ---------------------------------------------------------------------- 1 Name of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Persons ALLERGAN PHARMACEUTICALS (IRELAND) LTD., INC. - --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) |X| - --------- ---------------------------------------------------------------------- 3 SEC Use Only - --------- ---------------------------------------------------------------------- 4 Citizenship or Place of Organization PANAMA - --------- ---------------------------------------------------------------------- 5 Sole Voting Power Number of 2,245,944 ------ ----------------------------------------------- Shares 6 Shared Voting Power Beneficially Owned by Each Reporting Person 0 with ------ ----------------------------------------------- 7 Sole Dispositive Power 2,245,944 ------ ----------------------------------------------- 8 Shared Dispositive Power 0 - --------- ---------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by each Reporting Person 2,245,944 - --------- ---------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) excludes certain shares* - --------- ---------------------------------------------------------------------- 11 Percent of Class represented by amount in Row 9 5.3% - --------- ---------------------------------------------------------------------- 12 Type of Reporting Person* CO - --------- ---------------------------------------------------------------------- Page 3 of 7 pages 4 - --------------------------- 13G CUSIP NO. 53220K 10 8 - --------------------------- - --------- ---------------------------------------------------------------------- 1 Name of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Persons ALLERGAN HOLDINGS, INC. - --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group* (a) [ ] (b) |X| - --------- ---------------------------------------------------------------------- 3 SEC Use Only - --------- ---------------------------------------------------------------------- 4 Citizenship or Place of Organization DELAWARE - --------- ---------------------------------------------------------------------- 5 Sole Voting Power Number of 2,245,944 ------ ----------------------------------------------- Shares 6 Shared Voting Power Beneficially Owned by Each Reporting Person 0 with ------ ----------------------------------------------- 7 Sole Dispositive Power 2,245,944 ------ ----------------------------------------------- 8 Shared Dispositive Power 0 - --------- ---------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by each Reporting Person 2,245,944 - --------- ---------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) excludes certain shares* - --------- ---------------------------------------------------------------------- 11 Percent of Class represented by amount in Row 9 5.3% - --------- ---------------------------------------------------------------------- 12 Type of Reporting Person* CO - --------- ---------------------------------------------------------------------- Page 4 of 7 pages 5 ITEM 1. (a) Name of Issuer: Ligand Pharmaceuticals Incorporated ("Issuer") (b) Address of Issuer's Principal Executive Offices: 10275 Science Center Drive San Diego, CA 92121 ITEM 2. (a) Name of Person Filing: Allergan, Inc. Allergan Pharmaceuticals (Ireland) Ltd., Inc. Allergan Holdings, Inc. (b) Address of Principal Business Office or, if none, Residence: 2525 Dupont Drive Irvine, CA 92612 (c) Place of Organization: Allergan, Inc. - Delaware Allergan Pharmaceuticals (Ireland) Ltd., Inc. - Panama Allergan Holdings, Inc. - Delaware (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 53220K 10 8 ITEM 3. NOT APPLICABLE. ITEM 4. OWNERSHIP. (a) Amount Beneficially Owned: Each corporation beneficially owned 2,245,944 shares of Common Stock as of December 31, 1998. (b) Percent of Class: 5.3% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2,245,944 (ii) shares power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 2,245,944 (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: |X| ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable Page 5 of 7 pages 6 ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable. ITEM 10. CERTIFICATION Not applicable. Page 6 of 7 pages 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 5, 1999 Date ALLERGAN, INC. By: /s/ Douglas S. Ingram ------------------------------------------- Signature Douglas S. Ingram, Assistant Secretary ------------------------------------------- Name/Title ALLERGAN PHARMACEUTICALS (IRELAND) LTD., INC. By: /s/ Francis R. Tunney, Jr. ------------------------------------------- Signature Francis R. Tunney, Jr., Secretary ------------------------------------------- Name/Title ALLERGAN HOLDINGS, INC. By: /s/ Jeffrey L. Edwards ------------------------------------------- Signature Jeffrey L. Edwards, Treasurer ------------------------------------------- Name/Title Page 7 of 7 pages -----END PRIVACY-ENHANCED MESSAGE-----